This clinical guide synthesises peer-reviewed evidence, UK and international guidelines, and mechanistic data to provide a balanced framework for understanding GLP-1 medications and nutritional status
These are those with HIV-associated lipodystrophy
Initiation and Dosing Considerations Once a teen is deemed eligible, therapy must begin cautiously
News Release January 29, 2001 Some supplements for arthritis may exceed newly released safe intake levels for manganese WHITE PLAINS, NY January 29, 2001 ConsumerLab.com issued an alert today to its online readers that that some glucosamine and chondroitin products (popularly used for osteoarthritis), exceed newly established upper intake levels for manganese
: , , As hopeful as this is, a few big questions remain, especially if we care about equity and not just headlines: - Will oral GLP-1s actually be covered by insurers and employers as long term therapy, instead of short weight loss sprints followed by predictable regain - How will pricing and step edits work when a patient has already been on an injectable for more than a year - Will these trials and future studies meaningfully include the diverse, underrepresented communities that carry a disproportionate burden of obesity, sleep apnea, and cardiometabolic disease : - Set expectations early: discuss obesity as chronic disease, and proactively plan for maintenance before stopping anything
10.1038/nature18309 81 PetraC
